HORIBA Instruments Inc. 5390012206 DRI Cannabinoids 1 X 5 mL
The HORIBA Instruments, Inc. 5390012206 DRI® Cannabinoids calibration standard is designed for use in clinical laboratories and medical facilities, providing a reliable means for the calibration and validation of the DRI Cannabinoid Assay. This product is specifically intended for in vitro diagnostic use, offering a precise solution for detecting THC in human urine samples.
This calibration standard is part of the DRI Cannabinoid Assay system, which is used to quantify the presence of cannabinoids in human urine. The standard is supplied in a 5 mL vial and is used to ensure the accuracy and reliability of test results. By using this calibration standard, laboratories can confidently validate their assay results, ensuring compliance with regulatory requirements and providing accurate information for medical professionals.
Key Features
- Supplied in a 5 mL vial for convenient use
- Concentration of 100ng for precise calibration
- Designed for in vitro diagnostic use
- Used for the calibration and validation of the DRI Cannabinoid Assay
- Enables accurate detection of THC in human urine samples
- Supports compliance with regulatory requirements for laboratory testing
- Part of the DRI Cannabinoid Assay system for comprehensive testing solutions
Product Specifications
• Dimensions: Not specified • Weight: Not specified • Materials: Not specified • Compliance: For in vitro diagnostic use • Compatibility: Designed for use with the DRI Cannabinoid Assay systemIdeal For
• Clinical laboratories • Medical facilities • Toxicology labs • Forensic labs • Research institutions • Hospitals • Outpatient clinicsShare Product Link: